At Ca-Genome Rx, we leverage the transformative potential of ultra-low-cost genomic and transcriptomic sequencing paired with proprietary genomic biomarkers and mechanism-driven artificial intellegence tailored for genomics data. Our mission is to empower oncologists and patients with precise, actionable insights that not only optimize treatment decisions but also enhance survival rates and overall outcomes in the battle against cancer.
HIGH COVERAGE PRECISION THERAPEUTICS DELIVERED
ANALYZING
Proprietary genomic biomarkers and advanced machine learning tailored for genomics data
REPORTING
Ca-Genome Rx report, a revolutionary diagnostic tool to realize the power of low-cost omics.
PRECISION REPORTS FROM CA-GENOME RX's PROPRIETARY PIPELINE
Our proprietary pipeline seamlessly integrates state-of-the-art methodologies in next-generation sequencing (NGS), artificial intelligence (AI), and multi-omic data analytics.
HIGH POSITIVE RATES
Our proprietary pipeline seamlessly integrates state-of-the-art methodologies
Comprehensive CA-GENOME RX Report
Synthesizing complex datasets into accessible, patient-specific reports that provide critical and explanable insights into tumor antigen repertoires, regulatory networks, and therapeutic vulnerabilities.
AI-Powered Computational Analysis
Utilizing bespoke machine learning algorithms, including integral genomic signature analysis, to extract clinically actionable insights from high-dimensional data.
Novel Genomic Biomarkers
Advancing the discovery and validation of novel genomic markers, such as recurrent intragenic rearrangements and tumor-associated antigens, to ensure the pipeline remains at the forefront of scientific innovation.
